January 5, 2018, Biologix Corporation held the Distributor Conference of Beijing District in Beijing, Biologix distributors of Beijing and its surrounding areas attended.
Researchers at the Stanford University School of Medicine have come up with a way of conducting the therapy that, in mice, dramatically lowers its toxicity.
The U.S. Food and Drug Administration approved Foundation Medicine’s test for patients with advanced or widely spread cancers, and the Centers for Medicare and Medicaid Services proposed covering it.
Biologix will show the full laboratory consumables, instruments and complete biobanking solutions at booth A19, and we will be appreciated for your visiting.